Balyasny Asset Management
ARQT icon

Balyasny Asset Management’s Arcutis Biotherapeutics ARQT Stock Holding History

Balyasny Asset Management’s Portfolio ARQT Stock Details ARQT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
2025
Q1 		$6.69M Buy
2024
Q4 		$1.44M Buy
2024
Q3 		– Sell
2024
Q2 		$4.07M Sell
2024
Q1 		$7.74M Buy
2023
Q4 		– Sell
2023
Q3 		$202K Buy
2023
Q2 		– Sell
2023
Q1 		$487K Buy